![Melissa Zafirelis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Melissa Zafirelis
Hoofd Techniek/Wetenschap/O&O bij Hemoglobin Oxygen Therapeutics LLC
Profiel
Melissa Zafirelis is currently working as the Director of Regulatory Affairs & Clinical Operations at Hemoglobin Oxygen Therapeutics LLC.
She completed her undergraduate degree at the University of Massachusetts and her MBA at USC Marshall School of Business.
Actieve functies van Melissa Zafirelis
Bedrijven | Functie | Begin |
---|---|---|
Hemoglobin Oxygen Therapeutics LLC
![]() Hemoglobin Oxygen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Hemoglobin Oxygen Therapeutics LLC operates as a biotechnology company. It is focused on the development, manufacture and commercialization of a proprietary technology platform for oxygen-carrying solutions that address critical unmet medical needs in both human and veterinary medicine. The firm’s products include Hemopure and Oxyglobin. The company was founded by Zafiris G. Zafirelis and Igor Serov on February 18, 2014 and is headquartered in Souderton, PA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Melissa Zafirelis
University of Massachusetts | Undergraduate Degree |
USC Marshall School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Hemoglobin Oxygen Therapeutics LLC
![]() Hemoglobin Oxygen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Hemoglobin Oxygen Therapeutics LLC operates as a biotechnology company. It is focused on the development, manufacture and commercialization of a proprietary technology platform for oxygen-carrying solutions that address critical unmet medical needs in both human and veterinary medicine. The firm’s products include Hemopure and Oxyglobin. The company was founded by Zafiris G. Zafirelis and Igor Serov on February 18, 2014 and is headquartered in Souderton, PA. | Health Technology |